Curaxis Pharmaceutical Corp. is a specialty pharmaceutical company based in Alpharetta, Georgia.

Curaxis’ strategy is to initiate enrollment and dose the first patient in a Phase II clinical trial in women with mild to moderate Alzheimer’s disease in 2010. This major step for our Company will signify the next stage in the development of Curaxis Pharmaceutical and a major milestone towards commercialization of our treatment for Alzheimer’s Disease.

MORE ABOUT CURAXIS : CLICK HERE